Department of Anesthesiology, Baylor College of Medicine, Houston, TX 77030, USA.
Am J Physiol Regul Integr Comp Physiol. 2013 Jul 1;305(1):R60-7. doi: 10.1152/ajpregu.00126.2013. Epub 2013 May 1.
K2P6.1 or TWIK-2, a two-pore domain K channel, is an important regulator of cardiovascular function. K2P6.1 is highly expressed in vascular smooth muscle and endothelium. Mice (8-12 wk) lacking functional K2P6.1 (K2P6.1(-/-)) are hypertensive and have enhanced vascular contractility. It is not known whether the lack of functional K2P6.1 in endothelium has a role in the vascular dysfunction in K2P6.1(-/-) mice. We tested the hypothesis: K2P6.1(-/-) mice have impaired endothelium-dependent relaxations. K2P6.1(-/-) mice were ∼35 mmHg more hypertensive than WT mice at both 8-12 wk (young adult) and 20-24 wk (mature mice, P < 0.01; n = 8-10). Endothelium-dependent relaxations of the thoracic aorta were evaluated by isometric myography after contraction with phenylephrine (10(-6) M). Maximal ACh-dependent relaxations were increased from 65 ± 1% to 73 ± 1% in the aorta from young adult (P < 0.01; n = 6) and from 45 ± 1% to 74 ± 1% in the aorta from mature (P < 0.001; n = 5) K2P6.1(-/-) mice compared with K2P6.1(+/+) littermates. However, in the aorta from young adult and mature K2P6.1(+/+) mice, 10(-5) M indomethacin, a cyclooxygenase inhibitor, increased maximal ACh relaxations to knockout levels. Enhanced relaxation was also seen with ATP, a P2Y purinergic agonist, and A23187, a nonreceptor-based agonist in mature K2P6.1(-/-) mice. Mature adult aorta from K2P6.1(-/-) showed an attenuated ACh-mediated contraction in the presence of nitro-l-arginine methyl ester (l-NAME) and without precontraction of 0.97 mN vs. 7.5 mN in K2P6.1(-/-) and K2P6.1(+/+) (P < 0.001; n = 5). In summary, K2P6.1(-/-) mice, which are hypertensive, have enhanced endothelium-dependent relaxations in the aorta due to the suppression of an indomethacin-sensitive constrictor component.
K2P6.1 或 TWIK-2,双孔域 K 通道,是心血管功能的重要调节剂。K2P6.1 在血管平滑肌和内皮细胞中高度表达。缺乏功能性 K2P6.1(K2P6.1(-/-))的小鼠(8-12 周龄)高血压且血管收缩性增强。尚不清楚内皮细胞中缺乏功能性 K2P6.1 是否在 K2P6.1(-/-)小鼠的血管功能障碍中起作用。我们检验了以下假设:K2P6.1(-/-)小鼠的内皮依赖性舒张受损。与 WT 小鼠相比,K2P6.1(-/-)小鼠在 8-12 周龄(年轻成年)和 20-24 周龄(成熟小鼠)时血压分别高约 35 mmHg(P < 0.01;n = 8-10)。通过等长肌描记法评估胸主动脉的内皮依赖性舒张,收缩剂为苯肾上腺素(10(-6) M)。与 K2P6.1(+/+)同窝仔鼠相比,来自年轻成年(P < 0.01;n = 6)和成熟(P < 0.001;n = 5)K2P6.1(-/-)小鼠的主动脉中,ACh 依赖性最大舒张作用分别从 65 ± 1%增加到 73 ± 1%,从 45 ± 1%增加到 74 ± 1%。然而,在年轻成年和成熟 K2P6.1(+/+)小鼠的主动脉中,10(-5) M 吲哚美辛,一种环氧化酶抑制剂,将最大 ACh 舒张作用增加至敲除水平。在成熟的 K2P6.1(-/-)小鼠中,还观察到 ATP,一种 P2Y 嘌呤能激动剂和 A23187,一种非受体激动剂引起的增强舒张作用。在存在硝基-l-精氨酸甲酯(l-NAME)和无预收缩 0.97 mN 的情况下,成熟成年 K2P6.1(-/-)主动脉的 ACh 介导的收缩减弱,而 K2P6.1(-/-)和 K2P6.1(+/+)的收缩分别为 7.5 mN(P < 0.001;n = 5)。综上所述,由于抑制了吲哚美辛敏感的收缩成分,高血压的 K2P6.1(-/-)小鼠的主动脉具有增强的内皮依赖性舒张作用。